Sangamo BioSciences | SGMO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Alaunos Therapeutics USD 7M 2M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Alterity Therapeutics Limited AUD 47M 9M 2026-07
Amgen USD 189.89B 13.64B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 31.46B 4.55B 2026-07
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Cipla INR 1.14T 41.04B 2026-07
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 573.66M 46.63M 2026-07
CSL USD 55.89B 20.42B 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 82.36B 1.44B 2026-07
Ionis Pharmaceuticals USD 8.04B 5.06B 2026-07
J&J USD 602.98B 8.38B 2026-07
Karyopharm Therapeutics USD 1.12B 989M 2026-07
Merck USD 297.1B 35.84B 2026-03
Novartis USD 264.25B 23.66B 2026-07
Pfizer USD 153.81B 12.24B 2026-03
Roche Holding CHF 235.82B 34.18B 2026-07
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Tectonic Therapeutic USD 510M 70M 2026-07
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03